Forodesine
Forodesine is a transition state analog inhibitor that targets purine nucleoside phosphorylase, an enzyme involved in the purine salvage pathway. It is currently under investigation for its potential use in the treatment of cutaneous T-cell lymphoma (CTCL) and B-cell acute lymphoblastic leukemia (B-ALL).
Mechanism of Action[edit | edit source]
Forodesine inhibits the enzyme purine nucleoside phosphorylase (PNP), which plays a crucial role in the purine salvage pathway. This pathway is responsible for the recycling of purines in cells. By inhibiting PNP, forodesine disrupts the balance of purines in the cell, leading to an accumulation of deoxyguanosine triphosphate (dGTP) in lymphocytes. This accumulation triggers apoptosis, or programmed cell death, in these cells.
Clinical Trials[edit | edit source]
Forodesine has been investigated in several clinical trials for its potential use in treating various forms of cancer. In particular, it has shown promise in the treatment of cutaneous T-cell lymphoma (CTCL) and B-cell acute lymphoblastic leukemia (B-ALL).
In a Phase I/II trial for patients with refractory CTCL, forodesine demonstrated significant clinical activity. A Phase II trial for patients with relapsed or refractory B-ALL also showed promising results, with a significant number of patients achieving complete remission.
Side Effects[edit | edit source]
As with any drug, forodesine may cause side effects. The most common side effects reported in clinical trials include fatigue, nausea, and rash. Less common side effects include anemia, neutropenia, and thrombocytopenia.
Future Directions[edit | edit source]
Further research is needed to fully understand the potential of forodesine in cancer treatment. Ongoing and future clinical trials will continue to evaluate the drug's efficacy and safety profile in different patient populations and in combination with other therapies.
<img src=" " alt="" /> |
This chemical compound or drug related article is a stub. You can help WikiMD by expanding it. |
 | This oncology article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
